Trial intelligence / Profile preview

STS Injection for Symptomatic Venous Disease

NCT03363633Terminated

Start
Mar 2010
Primary completion
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of sodium tetradecyl sulfate in venous stasis (3 arms). Primary endpoint: Ulcer Healing at 12 months. Started Mar 2010; status: terminated.

02

Drugs

sodium tetradecyl sulfate
03

Conditions

venous stasis

Beyond the preview

Go deeper on NCT03363633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03363633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call